Suvretta Capital Management’s CalciMedica CALC Stock Holding History

Suvretta Capital Management’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,836	Closed	-$1.39M	–	109
2020 Q3	$1.39M	Buy	+7,836	New	+$1.63M	0.03%	84

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Suvretta Capital Management's CALC Position: Q4 2020 in Review

Suvretta Capital Management sold out of CalciMedica (CALC) in Q4 2020, closing a stake of 7,836 shares — an estimated $1.39M sold.

Suvretta Capital Management first reported a position in CALC in Q3 2020 and held it in 1 quarter. The position peaked at $1.39M in Q3 2020. 33 funds tracked by Wall St. Rank hold CALC as of Q4 2020.

Suvretta Capital Management reported no remaining CalciMedica position as of Q4 2020 after selling out during the quarter.
Suvretta Capital Management sold 7,836 CalciMedica shares in Q4 2020, an estimated $1.39M.
Suvretta Capital Management first reported a position in CalciMedica in Q3 2020 and held it in 1 quarter.
Suvretta Capital Management's CalciMedica position peaked at $1.39M in Q3 2020.
33 funds tracked by Wall St. Rank held CalciMedica as of Q4 2020.

Based on Suvretta Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.